Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Kedudukan dalam Saham #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in MalmΓΆ, Sweden.
Harga Saham
$0.00162013
Disegerakkan terakhir: 2025-01-03
Modal Pasaran
$156.25K
Perubahan (1 hari)
0.36%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Cyxone AB (publ) (CYXO)

Kategori

Bilangan saham terbitan bagi Cyxone AB (publ) (CYXO)
Bilangan saham terbitan setakat June 2024: 236.74M
Menurut laporan kewangan terkini dan harga saham Cyxone AB (publ), bilangan saham terbitan semasa ialah 236.74M. Pada akhir December 2022, syarikat mempunyai 95.77M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Cyxone AB (publ) (CYXO) dari 2015 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 236.74M 126.55%
2023 104.50M 9.11%
2022 95.77M 55.94%
2021 61.42M -0.61%
2020 61.79M 38.53%
2019 44.61M 15.51%
2018 38.61M 92.92%
2017 20.02M 25.22%
2016 15.98M 9.97%
2015 14.54M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
253.90M 7.25%
US
62.19M -73.73%
NL
- -
CH
- -
KR
0.00 -100.00%
BE